Placental growth factor testing for suspected pre-eclampsia: a cost-effectiveness analysis.

ABSTRACT:

Objective

To calculate the cost-effectiveness of implementing PlGF testing alongside a clinical management algorithm in maternity services in the UK, compared with current standard care.

Design

Cost-effectiveness analysis.

Setting

Eleven maternity units participating in the PARROT stepped-wedge cluster-randomised controlled trial.

Population

Women presenting with suspected pre-eclampsia between 20⁺⁰ and 36⁺⁶  weeks' gestation.

Methods

Monte Carlo simulation utilising resource use data and maternal adverse outcomes.

Main outcome measures

Cost per maternal adverse outcome prevented.

Results

Clinical care with PlGF testing costs less than current standard practice and resulted in fewer maternal adverse outcomes. There is

SUBMITTER: Duhig KE 

PROVIDER: S-EPMC6771855 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature